ArticleImmunity2026

Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment.

Vivien I Maltez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.